Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome

Glioblastoma: Imaging Genomic Mapping Reveals Sex-specific Oncogenic Associations of Cell Death

(2015) Rivka R. Colen et al.   RADIOLOGY

Anatomic features of glioblastoma and their potential impact on survival

(2014) U. Nestler et al.   ACTA NEUROCHIRURGICA

Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma

(2014) Matthew M. Grabowski et al.   JOURNAL OF NEUROSURGERY

Time window for postoperative reactive enhancement after resection of brain tumors: less than 72 hours

(2014) Stephanie Lescher et al.   Neurosurgical Focus

Open source software in a practical approach for post processing of radiologic images

(2014) Gianluca Valeri et al.   Radiologia Medica

Modeling and Testing Landslide Hazard Using Decision Tree

(2014) Mutasem Sh. Alkhasawneh et al.   Journal of Applied Mathematics

The Somatic Genomic Landscape of Glioblastoma

(2013) Cameron W. Brennan et al.   CELL

Glioblastoma and Other Malignant Gliomas

(2013) Antonio Omuro   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Initial and cumulative recurrence patterns of glioblastoma after temozolomide-based chemoradiotherapy and salvage treatment: a retrospective cohort study in a single institution

(2013) Kengo Ogura et al.   Radiation Oncology

Volumetric and MGMT parameters in glioblastoma patients: Survival analysis

(2012) Georgios Iliadis et al.   BMC CANCER

3D Slicer as an image computing platform for the Quantitative Imaging Network

(2012) Andriy Fedorov et al.   MAGNETIC RESONANCE IMAGING

A Novel Volume-Age-KPS (VAK) Glioblastoma Classification Identifies a Prognostic Cognate microRNA-Gene Signature

(2012) Pascal O. Zinn et al.   PLoS One

Glioma-related edema: new insight into molecular mechanisms and their clinical implications

(2012) Zhi-Xiong Lin   Chinese Journal of Cancer

Radiogenomic Mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme

(2011) Pascal O. Zinn et al.   PLoS One

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

(2010) Roel G.W. Verhaak et al.   CANCER CELL

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

(2010) Patrick Y. Wen et al.   JOURNAL OF CLINICAL ONCOLOGY

Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival

(2010) Kaisorn L. Chaichana et al.   JOURNAL OF NEUROSURGERY

Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy

(2009) Chul-Kee Park et al.   BMC CANCER

Peritumoral edema on MRI at initial diagnosis: an independent prognostic factor for glioblastoma?

(2009) K. Schoenegger et al.   EUROPEAN JOURNAL OF NEUROLOGY

Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation WithMGMTPromoter Methylation Status

(2009) Alba A. Brandes et al.   JOURNAL OF CLINICAL ONCOLOGY

EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME

(2009) et al.   NEUROSURGERY

Prognostic and Predictive Markers in Glioma and Other Neuroepithelial Tumors

(2008) Andreana L. Rivera et al.   CURRENT PROBLEMS IN CANCER

Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma

(2007) Graziella Filippini et al.   NEURO-ONCOLOGY